Filing Details
- Accession Number:
- 0001062993-24-003026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-13 17:48:49
- Reporting Period:
- 2024-02-12
- Accepted Time:
- 2024-02-13 17:48:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1994702 | Kyverna Therapeutics Inc. | KYTX | Biological Products, (No Disgnostic Substances) (2836) | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 882095 | Gilead Sciences, Inc. | 333 Lakeside Drive Foster City CA 94404 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-12 | 3,216,119 | $0.00 | 3,216,119 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2024-02-12 | 910,000 | $22.00 | 4,126,119 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A-2 Convertible Preferred Stock | Disposition | 2024-02-12 | 6,890,744 | $0.00 | 1,514,083 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2024-02-12 | 7,746,139 | $0.00 | 1,702,036 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Series A-2 Convertible Preferred Stock and the Series B Convertible Preferred Stock converted into Kyverna Therapeutics, Inc. common stock on a 4.5511-for-1 basis and had no expiration date.
- Reflects a 1-for-4.5511 reverse stock split, which became effective on January 30, 2024.
Billionaire Hedge Funds
